Rau, Andrea https://orcid.org/0000-0001-6469-488X
Passet, Bruno
Castille, Johan
Daniel-Carlier, Nathalie
Asset, Alexandre
Lecardonnel, Jérome
Moroldo, Marco
Jaffrézic, Florence
Laloë, Denis
Moazami-Goudarzi, Katayoun
Vilotte, Jean-Luc
Funding for this research was provided by:
INRAE Animal Genetics department (AAP.GA.2015, COSI-Net)
Article History
Received: 6 May 2022
Accepted: 13 June 2022
First Online: 7 July 2022
Declarations
:
: Animal experiments were carried out in accordance with the EU Directive 2010/63/EU. Production, breeding and inoculations at the one cell stage with <i>ShRNA</i>-lentiviral vectors of the various transgenic lines were approved by the Ethics Committee of Jouy-en-Josas (Comethea, Permit number 02532.01), and followed the safety recommendations of the French “Haut Conseil des Biotechnologies” (HCB, Permit numbers 6460 and 5468).
: The authors declare that they have no competing interests.